Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Stephenson

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Nature Clinical Practice. Urology|May 10, 2007
Identifying patients at risk for prostate-cancer-specific mortality: implications for clinical trial designAndrew J Stephenson
World Journal of Urology|April 17, 2009
Current treatment options for clinical stage I seminomaAndrew J Stephenson
Nature Clinical Practice. Urology|May 21, 2008
Is the Phoenix definition superior to ASTRO for predicting clinical outcomes in prostate cancer?Andrew J Stephenson
Urology|September 3, 2008
Re: Zhao et al.: External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400)Andrew J Stephenson
Nature Clinical Practice. Urology|November 22, 2007
Is obesity associated with biochemical recurrence in patients with prostate cancer?Andrew J Stephenson
The Journal of Urology|May 13, 2022
Pro: Magnetic Resonance Imaging Targeting Leads to Overtreatment of Prostate CancerAndrew J Stephenson, Srinivas Vourganti
Expert Review of Anticancer Therapy|September 20, 2017
Post-prostatectomy radiation therapy for locally recurrent prostate cancerSudhir Isharwal, Andrew J Stephenson
The Urologic Clinics of North America|July 29, 2015
Management of Stage I Nonseminomatous Germ Cell TumorsEvan Kovac, Andrew J Stephenson
Current Treatment Options in Oncology|August 19, 2005
Management of patients with low-stage nonseminomatous germ cell testicular cancerAndrew J Stephenson, Joel Sheinfeld
Urologic Oncology|July 24, 2004
The role of retroperitoneal lymph node dissection in the management of testicular cancerAndrew J Stephenson, Joel Sheinfeld
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Nature Clinical Practice. Urology|May 10, 2007
Identifying patients at risk for prostate-cancer-specific mortality: implications for clinical trial designAndrew J Stephenson
World Journal of Urology|April 17, 2009
Current treatment options for clinical stage I seminomaAndrew J Stephenson
Nature Clinical Practice. Urology|May 21, 2008
Is the Phoenix definition superior to ASTRO for predicting clinical outcomes in prostate cancer?Andrew J Stephenson
Urology|September 3, 2008
Re: Zhao et al.: External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment Score (Urology 2008;72:396-400)Andrew J Stephenson
Nature Clinical Practice. Urology|November 22, 2007
Is obesity associated with biochemical recurrence in patients with prostate cancer?Andrew J Stephenson
The Journal of Urology|May 13, 2022
Pro: Magnetic Resonance Imaging Targeting Leads to Overtreatment of Prostate CancerAndrew J Stephenson, Srinivas Vourganti
Expert Review of Anticancer Therapy|September 20, 2017
Post-prostatectomy radiation therapy for locally recurrent prostate cancerSudhir Isharwal, Andrew J Stephenson
The Urologic Clinics of North America|July 29, 2015
Management of Stage I Nonseminomatous Germ Cell TumorsEvan Kovac, Andrew J Stephenson
Current Treatment Options in Oncology|August 19, 2005
Management of patients with low-stage nonseminomatous germ cell testicular cancerAndrew J Stephenson, Joel Sheinfeld
Urologic Oncology|July 24, 2004
The role of retroperitoneal lymph node dissection in the management of testicular cancerAndrew J Stephenson, Joel Sheinfeld
Pageof 17